Not necessarily. Interim data is being compiled and analyzed for a stated release 1st week of December.
The full release of completed trial data will be 2 months after last patient dosed. Two weeks treatment, 2 weeks follow-up, and then a month to compile the data and digest it.
Interim data is coming long before the complete trial data is known because THEY ALREADY KNOW IT WORKS!, imo. (Sorry for shouting).
Either that or they just committed to a partial readout where anything but overwhelming positive data will be a non-issue and irrelevant to investor confidence.
Share price suicide.
I will stay confident our good Dr Williams did not "jump the shark" and take a "shot in the dark" with interim data, without already knowing.